Thursday 23 March 2017
9.30am - 10.00am Registration and morning coffee

10.00am - 10.05am

Welcome and Official Opening
Glenn Cross, Chief Executive Officer, AusBiotech

10.05am - 10.35am

KEYNOTE: Update on the current state of life science investing in Asia

Judith Li,
Partner, Lilly Asia Ventures

10.35am - 11.15am

Company Spotlight Presentations

A/Prof David Anderson, President, Nanajing BioPoint Diagnostic Technology
A/Prof Heidi Drummer,
 Program Head for Disease Elimination, HepSeeVax (Burnet Institute)
David Ranson,
Chairman, FivepHusion Pty Ltd
Dr Richard Lipscombe,
Managing Director, Proteomics International

11.15am - 11.45am Morning tea and networking opportunity

11.45am - 12.15pm

KEYNOTE: Raising capital for international life science companies - A Case Study
Speaker:
Donald Xu,
Lynx Financial

12.15pm - 1.00pm

Company Spotlight Presentations

Dr James Garner
Chief Executive Officer, Novogen
Philip Crealy,
Director - Translational Research, Petri Exchange
Dr Leearne Hinch,
Chief Executive Officer, BARD1 Life Science Ltd
Peter Molloy,
Managing Director & CEO, Race Oncology

1.00pm - 2.25pm

Lunch and networking opportunity

2.25pm - 3.15pm

Company Spotlight Presentations

Michael Kleinig,
CEO & Managing Director, GO Resources
Paul Rennie,
Managing Director, Paradigm Pharma
Ross Macdonald,
Managing Director and CEO Cynata Therapeutics
Justin Zhang, Business Development Executive, Global M&A, Wondfo
Roc Zhang,
International Sales Manager, Daan Gene Co Ltd

3.15pm - 3.45pm

KEYNOTE: R&D incentives landscape in Australia: reducing the costs of project development and implementation for investors and managers
Speaker:
Alan Garcia,
Partner, Tax, KPMG Australia

3.45pm - 4.00pm Close of Conference
Glenn Cross,
Chief Executive Officer, AusBiotech

4.00pm - 5.00pm Networking Reception
Venue: KPMG Hong Kong

Tweets by @AusBiotech